APOLLO HOSPITALS ENTER. L vs BROOKS LAB LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and BROOKS LAB LIMITED (BROOKS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs BROOKS on 7 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
8.33
13.42
P/B ratio
1.82
0.11%
Dividend yield
0.00%
₹135.04
EPS
₹8.34

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
22.30%
18.00%
Return on capital
21.00%
15.00%
EBITDA margin
8.00%
7.94%
Net margin
29.07%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
10.93%
33.39%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹205 Cr
₹25,228 Cr
Revenue
₹86 Cr
₹2,003 Cr
Net profit
₹25 Cr
0.90
Debt / equity
0.07
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
BROOKS LAB LIMITED
  • + ["Company is almost debt free.", "Company has delivered good profit growth of 26.8% CAGR over last 5 years"]
  • ["The company has delivered a poor sales growth of 2.11% over past five years.", "Company has a low return on equity of -1.91% over last 3 years.", "Contingent liabilities of Rs.75.7 Cr.", "Earnings include an other income of Rs.20.0 Cr.", "Promoter holding has decreased over last 3 years: -13.8%"]
APOLLO HOSPITALS ENTER. L full analysis BROOKS LAB LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.